Goodoory V - Search Results

1

Infliximab induction regimens in steroid-refractory acute severe colitis: a multicentre retrospective cohort study with propensity score analysis.

Sebastian S, Myers S, Argyriou K, Martin G, Los L, Fiske J, Ranjan R, Cooper B, Goodoory V, Ching HL, Jayasooriya N, Brooks J, Dhar A, Shenoy AH, Limdi JK, Butterworth J, Allen PB, Samuel S, Moran GW, Shenderey R, Parkes G, Lobo A, Kennedy NA, Subramanian S, Raine T. Sebastian S, et al. Among authors: goodoory v. Aliment Pharmacol Ther. 2019 Sep;50(6):675-683. doi: 10.1111/apt.15456. Aliment Pharmacol Ther. 2019. PMID: 31456297

2

Novel Symptom Subgroups in Individuals With Irritable Bowel Syndrome Predict Disease Impact and Burden.

Black CJ, Ng CE, Goodoory VC, Ford AC. Black CJ, et al. Clin Gastroenterol Hepatol. 2024 Feb;22(2):386-396.e10. doi: 10.1016/j.cgh.2023.02.016. Epub 2023 Feb 27. Clin Gastroenterol Hepatol. 2024. PMID: 36858142 Free article.

3

Systematic Review and Meta-analysis: Efficacy of Mesalamine in Irritable Bowel Syndrome.

Goodoory VC, Tuteja AK, Black CJ, Ford AC. Goodoory VC, et al. Clin Gastroenterol Hepatol. 2024 Feb;22(2):243-251.e5. doi: 10.1016/j.cgh.2023.02.014. Epub 2023 Feb 27. Clin Gastroenterol Hepatol. 2024. PMID: 36858143 Free article. Review.

4

Willingness to accept risk with medication in return for cure of symptoms among patients with Rome IV irritable bowel syndrome.

Goodoory VC, Ng CE, Black CJ, Ford AC. Goodoory VC, et al. Aliment Pharmacol Ther. 2022 May;55(10):1311-1319. doi: 10.1111/apt.16816. Epub 2022 Feb 15. Aliment Pharmacol Ther. 2022. PMID: 35166374 Free PMC article.

5

Direct healthcare costs of Rome IV or Rome III-defined irritable bowel syndrome in the United Kingdom.

Goodoory VC, Ng CE, Black CJ, Ford AC. Goodoory VC, et al. Aliment Pharmacol Ther. 2022 Jul;56(1):110-120. doi: 10.1111/apt.16939. Epub 2022 May 1. Aliment Pharmacol Ther. 2022. PMID: 35491477 Free PMC article.

6

Editorial: work and activity impairment are important considerations to optimise treatment plans for irritable bowel syndrome. Authors' reply.

Goodoory VC, Ng CE, Black CJ, Ford AC. Goodoory VC, et al. Aliment Pharmacol Ther. 2022 Sep;56(5):894-895. doi: 10.1111/apt.17160. Aliment Pharmacol Ther. 2022. PMID: 35934862 No abstract available.

7

Factors associated with lower disease-specific and generic health-related quality of life in Rome IV irritable bowel syndrome.

Goodoory VC, Guthrie EA, Ng CE, Black CJ, Ford AC. Goodoory VC, et al. Aliment Pharmacol Ther. 2023 Feb;57(3):323-334. doi: 10.1111/apt.17356. Epub 2022 Dec 21. Aliment Pharmacol Ther. 2023. PMID: 36544055 Free article.

8

Prevalence and impact of faecal incontinence among individuals with Rome IV irritable bowel syndrome.

Goodoory VC, Ng CE, Black CJ, Ford AC. Goodoory VC, et al. Aliment Pharmacol Ther. 2023 May;57(10):1083-1092. doi: 10.1111/apt.17465. Epub 2023 Mar 13. Aliment Pharmacol Ther. 2023. PMID: 36914979 Free article.

9

Editorial: faecal incontinence is prevalent in IBS, as are effective treatment options! Authors' reply.

Goodoory VC, Ng CE, Black CJ, Ford AC. Goodoory VC, et al. Aliment Pharmacol Ther. 2023 May;57(10):1176-1177. doi: 10.1111/apt.17494. Aliment Pharmacol Ther. 2023. PMID: 37094322 No abstract available.

10

Letter: Does irritable bowel syndrome have a greater impact in Western, compared with Asian, patients? Authors' reply.

Goodoory VC, Guthrie EA, Ng CE, Black CJ, Ford AC. Goodoory VC, et al. Aliment Pharmacol Ther. 2023 May;57(10):1190-1191. doi: 10.1111/apt.17497. Aliment Pharmacol Ther. 2023. PMID: 37094324 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters